WuXi AppTec (Tianjin) Co., Ltd.
Established in 2006 with a registered capital of RMB 600 million, WuXi AppTec (Tianjin) Co., Ltd. is positioned to be the northern R&D center of WuXi AppTec Group, and is one of the most comprehensive and strongest integrated discovery, research and development service platforms for small molecule chemical drugs. The Company is mainly engaged in preclinical research of small molecule chemical drugs, providing services such as lead compound discovery, drug template synthesis, drug compound library synthesis, and small molecule drug process development. The Company has successively won honors such as China’s Top Ten Leading Enterprises in Service Outsourcing, National High-tech Enterprises, and Tianjin Service Enterprises with Advanced Technologies.
